Fluorofuranylnorprogesterone F-18 is under investigation in clinical trial NCT02455453 (Assessment of Functional Status of Estrogen Receptors in Breast Cancer by Positron Emission Tomography). FLUOROFURANYLNORPROGESTERONE F-18 is a small molecule drug with a maximum clinical trial phase of II. Its therapeutic use is listed as diagnostic agents. The directory classifies it as a clinical API with a semi-synthetic source/manufacturing origin. Other names for this substance include 18F-Ffnp. Its PubChem CID is 15251064.
Fluorofuranylnorprogesterone F-18
| CAS No | 160388-43-2 |
|---|---|
| Molecular Formula | C25H29FO5 |
| Molecular Weight | 427.50 g/mol |
| Synonyms | (1R,2S,4R,6R,8S,9S,12S,13R)-8-(2-(18F)fluoranylacetyl)-6-(furan-2-yl)-9-methyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icos-17-en-16-one |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Fluorofuranylnorprogesterone F-18 is under investigation in clinical trial NCT02455453 (Assessment of Functional Status of Estrogen Receptors in Breast Cancer by Positron Emission Tomography).
The listed CAS number is 160388-43-2.
The listed molecular formula is C25H29FO5.
The listed molecular weight is 427.50 g/mol.
(1R,2S,4R,6R,8S,9S,12S,13R)-8-(2-(18F)fluoranylacetyl)-6-(furan-2-yl)-9-methyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icos-17-en-16-one.
The source lists 18F-Ffnp.